CNSP

CNS Pharmaceuticals, Inc.

Nasdaq · Pharmaceutical Preparations · Inc. NV · CIK 0001729427
$5.27 +4.36% $7.4M
High Impact Filing (7/10)
Vol
Market Cap$7.4M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$21.00
Inst. Activity1 buys / 1 sells
Insider Activity1B / 0S
Insider Net $$34.0K
Reddit Sentiment75° Bullish
SEC Reports2
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. NV·CIK 0001729427·Prev Close $5.05

Recent Activity

May 19, 2026 SEC
CNS Pharmaceuticals filed a resale S-3 registering up to 9,793,479 shares (650,000 common + 9,143,479 pre-funded warrant
S-3 — Impact 7/10
May 18, 2026 Insider
Charles Faith L. bought 7,100 shares
Director @ $4.79 ($34.0K)
May 13, 2026 earnings_calendar
CNSP Q1 2026 Earnings Scheduled — 2026-05-13
May 4, 2026 SEC
CNS Pharmaceuticals entered into a securities purchase agreement for a private placement of common stock and pre-funded
8-K — Impact 7/10
Mar 2, 2026 Insider
Faulkner Eric sold 9,500 shares
Chief Technology Officer @ $0.00 ($0.00)
Mar 2, 2026 Insider
O'Loughlin Steve sold 9,500 shares
Chief Financial Officer @ $0.00 ($0.00)
Inst.
UBS Group AG — NEW
10,520 shares ($94.7K)
Inst.
UBS Group AG — EXIT
0 shares ($0.00)

Price Targets

Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$10.00 (Sep 2025)
Current $5.27 Low $10.00 Median $10.00 High $10.00 1 analysts
$10.00 $10.00

Analyst Ratings

Historical distribution88% buy · 8 analysts · last covering-analyst action Sep 2025
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Sep 12, 2025 Maxim Group UPGRADE Hold → Buy
Mar 25, 2025 Maxim Group DOWNGRADE Buy → Hold

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.24 ▲ +65.2% $-0.24 — $-0.24 96% YoY 1
Next Q $-0.27 ▲ +63.5% $-0.27 — $-0.27 95% YoY 1
Current FY $-1.65 ▲ +55.0% $-1.65 — $-1.65 95% YoY 1
Next FY $-1.66 ▲ +42.6% $-1.66 — $-1.66 -1% YoY 1

Top Institutional Holders

FundValueMove
BANK OF AMERICA CORP$21.00DOUBLED

Recent Insider Trades

DateInsiderTypeValue
May 18, 2026Charles FaithBUY$34.0K
Mar 2, 2026Faulkner EricA$0.00
Mar 2, 2026O'Loughlin SteveA$0.00

Reddit Sentiment

75°
Bullish
Bearish Neutral Bullish
4 mentions 4 bullish 0 bearish
1 institutional holders with $21.00 total value (4 shares) as of 2025-Q4. Top holders: BANK.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1BANK OF AMERICA CORP /DE/4$21.00100.0%DOUBLED +444.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGNEW10,520$94.7K2025-Q3
UBS Group AGEXIT32,1030-100.0%$0.002025-Q3
UBS Group AGADD23,97832,103+33.9%$26.5K2025-Q2
BANK OF AMERICA CORP /DE/DOUBLED949+444.4%$40.002025-Q2
UBS Group AGNEW23,978$32.6K2025-Q1
3 unique insiders with 1 transactions. Net insider value: $34.0K ($34.0K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 18, 2026Charles Faith L.DirectorBUY7,100$4.79$34.0K
Mar 2, 2026Faulkner EricChief Technology OfficerA9,500$0.00$0.00
Mar 2, 2026O'Loughlin SteveChief Financial OfficerA9,500$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Sep 2025): 88% buy across 8 analysts — 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$10.00 mean target (Sep 2025)
$10.00 Low $10.00 High
MetricValue
Current Price$5.27
Target Low$10.00
Target Mean$10.00
Target Median$10.00
Target High$10.00
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.24 $-0.24 $-0.24 96.3% +65.2% $0.0B 1
Next Q
2026-09-30
$-0.27 $-0.27 $-0.27 95.3% +63.5% $0.0B 0.0% 1
Current FY
2026-12-31
$-1.65 $-1.65 $-1.65 95.4% +55.0% 1↑ 0↓ $0.0B 0.0% 1
Next FY
2027-12-31
$-1.66 $-1.66 $-1.66 -0.6% +42.6% 1↑ 0↓ $0.0B 0.0% 1

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.240
7d ago$-0.690+0.450
30d ago$-0.690+0.450
60d ago$-0.690+0.450
90d ago$0.000-0.240
1 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Sep 12, 2025 Maxim Group UPGRADE Hold Buy
Mar 25, 2025 Maxim Group DOWNGRADE Buy Hold

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20262510088%
Apr 1, 20262510088%
Mar 1, 20262510088%
Feb 1, 20262510088%
Jan 1, 20262510088%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

75°
Bullish
Bearish Neutral Bullish
4 mentions 4 bullish 0 bearish 4 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 4, 2026160° Warm101
May 4, 2026160° Warm101
May 4, 2026160° Warm101
May 4, 2026160° Warm101

Recent Reddit Threads

r/pennystocks Bullish 17d 19h ago
Day 2 million in motion
▲ 1 💬 1 ⚡ 0.5
r/pennystocks Bullish 17d 17h ago
$CNSP +21% — $22.5M oversubscribed PIPE at $2.30, stock ran to $10+
▲ 1 💬 1 ⚡ 0.5
May 13, 2026
earnings_calendar
CNSP Q1 2026 Earnings Scheduled — 2026-05-13
Mar 30, 2026
earnings_calendar
CNSP Q4 2025 Earnings After Market Close — 2026-03-30